234 related articles for article (PubMed ID: 2848062)
1. Seronegative blood products prevent primary cytomegalovirus infection after bone marrow transplantation.
Mackinnon S; Burnett AK; Crawford RJ; Cameron S; Leask BG; Sommerville RG
J Clin Pathol; 1988 Sep; 41(9):948-50. PubMed ID: 2848062
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation.
Bowden RA; Sayers M; Flournoy N; Newton B; Banaji M; Thomas ED; Meyers JD
N Engl J Med; 1986 Apr; 314(16):1006-10. PubMed ID: 3007984
[TBL] [Abstract][Full Text] [Related]
3. Prevention of primary cytomegalovirus infection after allogeneic bone marrow transplantation by using leukocyte-poor random blood products from cytomegalovirus-unscreened blood-bank donors.
De Witte T; Schattenberg A; Van Dijk BA; Galama J; Olthuis H; Van der Meer JW; Kunst VA
Transplantation; 1990 Dec; 50(6):964-8. PubMed ID: 2175059
[TBL] [Abstract][Full Text] [Related]
4. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
[TBL] [Abstract][Full Text] [Related]
5. Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening.
Miller WJ; McCullough J; Balfour HH; Haake RJ; Ramsay NK; Goldman A; Bowman R; Kersey J
Bone Marrow Transplant; 1991 Mar; 7(3):227-34. PubMed ID: 1647829
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
7. [Importance of screening for antibodies to cytomegalovirus in organ transplantation].
Milbradt H; Flik J; Stangel W; Heigel R
Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866
[TBL] [Abstract][Full Text] [Related]
8. [Cytomegalovirus hyperimmune globulin prophylaxis in bone marrow transplants in children with various diseases].
Ebell W; Blütters-Sawatzki R; Friedrich W; Hampl W; Kleihauer E
Immun Infekt; 1985 Nov; 13(6):307-12. PubMed ID: 3000925
[TBL] [Abstract][Full Text] [Related]
9. Bedside leukoreduction of cellular blood components in preventing cytomegalovirus transmission in allogeneic bone marrow transplant recipients: a retrospective study.
Narvios AB; Lichtiger B
Haematologica; 2001 Jul; 86(7):749-52. PubMed ID: 11454531
[TBL] [Abstract][Full Text] [Related]
10. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
[TBL] [Abstract][Full Text] [Related]
11. Immune donors can protect marrow-transplant recipients from severe cytomegalovirus infections.
Grob JP; Grundy JE; Prentice HG; Griffiths PD; Hoffbrand AV; Hughes MD; Tate T; Wimperis JZ; Brenner MK
Lancet; 1987 Apr; 1(8536):774-6. PubMed ID: 2882184
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.
Schmeiser T; Heit W; Arnold R; Bunjes D; Wiesneth M; Hertenstein B; Hampl W; Heimpel H
Klin Wochenschr; 1987 Oct; 65(20):967-74. PubMed ID: 2828758
[TBL] [Abstract][Full Text] [Related]
13. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
[TBL] [Abstract][Full Text] [Related]
14. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
[TBL] [Abstract][Full Text] [Related]
15. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
Huart JJ; Baume D; Jouet JP
Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection.
Atkinson K; Downs K; Golenia M; Biggs J; Marshall G; Dodds A; Concannon A
Br J Haematol; 1991 Sep; 79(1):57-62. PubMed ID: 1654994
[TBL] [Abstract][Full Text] [Related]
18. [Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients].
Beelen DW; Neumann MC; Mahmoud HK; Henneberg K; Thraenhart O; Schaefer UW
Immun Infekt; 1985 Sep; 13(5):229-32. PubMed ID: 2998980
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.
Meyers JD; Leszczynski J; Zaia JA; Flournoy N; Newton B; Snydman DR; Wright GG; Levin MJ; Thomas ED
Ann Intern Med; 1983 Apr; 98(4):442-6. PubMed ID: 6301320
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
